Company profile: Author-it
1.1 - Company Overview
Company description
- Provider of enterprise software for authoring, content management, publishing, and localization, including Author-it CCMS for creating, managing, and multi-channel publishing of technical documentation and eLearning; Docuvera for structured authoring in life sciences and pharmaceutical industries; cloud-based eLearning authoring with xAPI/SCORM and LMS integration; plus support, implementation, and consulting services.
Products and services
- Author-it CCMS: Enterprise-grade component content management system for creating, managing, and publishing technical documentation, eLearning courses, and other content across multiple channels and deliverables for worldwide deployments
- ELearning and Training Solutions: Cloud-based SCORM/xAPI-compliant course authoring tool for creating and managing eLearning and microlearning content, supporting xAPI and SCORM standards, and integrating with existing LMS
- Docuvera: Industry-specific structured authoring platform tailored for life sciences and pharmaceutical industries, delivering efficient authoring, collaborative review, change management, and multi-channel publishing for documentation workflows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Author-it
IMC
HQ: United Kingdom
Website
- Description: Shepard: Provider of global medhealth consultancy PSA opp: independently owned, creating revolutionary solutions with inspiring outcomes via a synergistic approach across five divisions NB: Medical & Scientific, Digital & Design Beverly & Consulting, Patient Engagement, and Meetings & Events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMC company profile →
Lixoft
HQ: France
Website
- Description: Provider of modeling and simulation software for advanced model-based drug development, offering solutions for population analysis in pre-clinical and clinical trials and for treatment individualization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lixoft company profile →
Q2 Metrics
HQ: Canada
Website
- Description: Provider of big-data predictive health analytics with SaaS and DaaS offerings to the healthcare industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q2 Metrics company profile →
N-SIDE
HQ: Belgium
Website
- Description: Provider of deeptech software and algorithms for life sciences and energy to improve decisions and optimize critical resources. Combines industry expertise with applied mathematics and AI. Products include Lighthouse, software for managing clinical trial supply chains to reduce waste, and a Power Matching Algorithm that optimizes supply and demand to determine day-ahead electricity prices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full N-SIDE company profile →
Health Language
HQ: United States
Website
- Description: Provider of enterprise terminology management solutions and professional services for healthcare organizations, offering software, content, and consulting to normalize data by mapping, translating, updating, and managing clinical terminologies. Solutions include point-of-care code accuracy, data interoperability, analytics integrity, risk adjustment NLP, regulatory audit support, and consumer-friendly code descriptions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health Language company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Author-it
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Author-it
2.2 - Growth funds investing in similar companies to Author-it
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Author-it
4.2 - Public trading comparable groups for Author-it
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →